Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Health Care
CA. TargeGen primarily develops small molecule kinase inhibitors for applications in oncology and inflammatory diseases.
Inc. is a privately held biopharmaceutical company based in San Diego
Biopharma
TargeGen
Date founded
2002
Funding rounds raised
Total raised
$40M
from 14 investors over 14 rounds
T
TargeGen, Inc. raised $40M on July 12, 2007
Investors: Tekla Healthcare Investors, Enterprise Partners Venture Capital, Pappas Ventures, Chicago Growth Partners, VantagePoint Venture Partners and Forward Ventures
T
TargeGen, Inc. raised $30M on September 26, 2005
Investors: Enterprise Partners Venture Capital, Williams Investors Llc and Forward Ventures
T
TargeGen, Inc. raised $30M on January 15, 2004
Investors: Williams Investors Llc, Enterprise Partners Venture Capital and Forward Ventures
T
TargeGen, Inc. raised $10M on May 31, 2002
Investors: Enterprise Partners Venture Capital and Forward Ventures